Ligand validation:6Y9D

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Y9D_EPE_A_405	4%	15%	0.257	0.634	2.23	1.54	1	4	0	0	100%	1
6Y9D_EPE_J_405	4%	19%	0.236	0.598	2.08	1.37	1	1	3	0	100%	1
6Y9D_EPE_I_405	3%	25%	0.256	0.606	1.04	1.99	1	7	0	0	100%	1
6Y9D_EPE_L_405	3%	27%	0.342	0.677	0.96	1.95	1	9	0	0	100%	1
6Y9D_EPE_H_405	2%	28%	0.311	0.619	1.06	1.82	1	8	0	0	100%	1
6Y9D_EPE_D_405	2%	24%	0.304	0.594	0.96	2.1	1	8	0	0	100%	1
6Y9D_EPE_B_405	2%	27%	0.302	0.581	0.98	1.94	1	7	0	0	100%	1
6Y9D_EPE_K_405	2%	28%	0.289	0.531	0.97	1.89	1	7	0	0	100%	1
6Y9D_EPE_F_405	1%	27%	0.382	0.586	1.06	1.86	1	5	0	0	100%	1
6Y9D_EPE_C_405	1%	27%	0.411	0.589	1.13	1.79	1	7	0	0	100%	1
6Y9D_EPE_E_405	1%	26%	0.339	0.489	1.03	1.92	1	8	0	0	100%	1
6Y9D_EPE_G_405	1%	27%	0.329	0.478	1.06	1.84	1	5	0	0	100%	1
6ZGP_EPE_E_404	13%	20%	0.254	0.792	1.21	2.15	1	5	1	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1
2F9R_EPE_B_701	99%	44%	0.061	0.989	0.62	1.54	-	2	0	0	100%	1
1VSI_EPE_A_261	98%	15%	0.058	0.984	1.64	2.09	1	6	1	0	100%	1
1XX1_EPE_D_2004	98%	26%	0.063	0.987	0.79	2.15	1	6	1	0	100%	1
4WYD_EPE_B_503	98%	44%	0.065	0.989	0.93	1.23	1	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.